Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Rituximab is used in all of the following conditions except:

Paroxysmal nocturnal hemoglobinuria. ***Paroxysmal nocturnal hemoglobinuria*** - **Eculizumab**, a C5 complement inhibitor, is the primary treatment for paroxysmal nocturnal hemoglobinuria to prevent complement-mediated hemolysis and thrombosis. - Rituximab targets CD20 B cells and would not directly address the underlying complement dysregulation in PNH. *Non-Hodgkin lymphoma* - Rituximab is a cornerstone of therapy, especially for **B-cell non-Hodgkin lymphomas**, as it targets the CD20 antigen expressed on malignant B cells. - It is often used in combination with chemotherapy regimens like **R-CHOP** (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone). *Rheumatoid arthritis* - Rituximab is approved for the treatment of **moderate to severe rheumatoid arthritis** in patients who have had an inadequate response to TNF inhibitors. - It works by depleting B cells, which play a role in the autoimmune pathogenesis of RA. *Systemic lupus erythematosus* - While not officially FDA-approved for SLE, rituximab is used **off-label** in some severe, refractory cases of SLE, particularly those with significant renal or hematological involvement. - It targets B cells, which are central to autoantibody production and immune complex formation in SLE.

Q: Which drug is contraindicated in a patient with a history of porphyria?

Thiopental. ***Thiopental*** - **Thiopental** is a **barbiturate** known to induce **delta-aminolevulinic acid (ALA) synthase**, which is the rate-limiting enzyme in **heme synthesis**. - This enzyme induction can precipitate acute attacks in patients with **porphyria**, a group of genetic disorders affecting heme production. *Propofol* - **Propofol** is a widely used intravenous anesthetic that is generally considered **safe** in patients with porphyria. - It does not significantly stimulate **ALA synthase** activity or interfere with heme metabolism. *Midazolam* - **Midazolam** is a **benzodiazepine** used for sedation and anesthesia. Like propofol, it is generally considered **safe** in patients with porphyria. - Benzodiazepines do not typically induce **porphyrin synthesis**. *Etomidate* - **Etomidate** is an intravenous anesthetic that acts as a GABA-A receptor modulator. It is also generally considered **safe** for use in patients with porphyria. - While etomidate can sometimes have mild effects on steroid synthesis, it does not significantly impact the **heme biosynthesis pathway** in a way that would trigger porphyric attacks.

Q: A patient undergoing chemotherapy with cisplatin is at high risk for nephrotoxicity. Which preventive measure should be prioritized?

Aggressive intravenous hydration with saline. Aggressive intravenous hydration with saline - Cisplatin is highly nephrotoxic, and aggressive hydration with normal saline is the primary and most effective method to reduce renal toxicity by promoting diuresis and flushing the drug through the kidneys [1]. - This approach helps to decrease the concentration of cisplatin in the renal tubules and minimize its direct toxic effects on renal cells [1]. Administration of amifostine - Amifostine is a cytoprotective agent that can be used to reduce cisplatin-induced nephrotoxicity, but it is typically used as an adjunct to hydration, not as the primary or prioritized measure. - Its use can be associated with side effects such as hypotension and nausea, making hydration a more universally applicable primary strategy. Switch to carboplatin - While carboplatin is less nephrotoxic than cisplatin, it is not always a suitable alternative due to differences in efficacy, spectrum of activity, and different toxicity profiles (e.g., more myelosuppression). - Replacing cisplatin with carboplatin significantly alters the chemotherapy regimen, which may compromise treatment efficacy against certain cancers. Dose reduction of cisplatin - Dose reduction can decrease nephrotoxicity but may also compromise the efficacy of chemotherapy, leading to suboptimal cancer treatment outcomes. - It is generally considered a last resort or when toxicity occurs despite optimal preventive measures, rather than a primary preventive measure itself.

Q: A 60-year-old woman on warfarin (INR 6.5) presents with severe gastrointestinal bleeding and hemodynamic instability. Which intervention would most rapidly reverse the anticoagulation?

Fresh frozen plasma. ***Correct: Fresh frozen plasma*** Among the options provided, **fresh frozen plasma (FFP)** is the most appropriate for rapid warfarin reversal in this emergency with severe bleeding and hemodynamic instability. **Why FFP is correct:** - Contains all vitamin K-dependent clotting factors (II, VII, IX, X) depleted by warfarin - Provides immediate source of functional clotting factors - Can begin reversing anticoagulation within 30-60 minutes - Appropriate for life-threatening bleeding when prothrombin complex concentrate (PCC) is unavailable **Clinical Note:** In current practice, 4-factor PCC is preferred over FFP for warfarin reversal due to faster action (10-15 minutes), smaller volume, and more predictable INR correction. However, PCC is not among the listed options. *Incorrect: Vitamin K* - Takes 6-24 hours to synthesize new clotting factors - Too slow for acute, life-threatening bleeding - Should be given alongside FFP/PCC but cannot provide rapid reversal alone - Appropriate for non-urgent INR correction *Incorrect: Protamine sulfate* - Reverses heparin and low molecular weight heparins, NOT warfarin - Works by directly binding and neutralizing heparin - No effect on vitamin K-dependent clotting factors *Incorrect: Desmopressin* - Increases Factor VIII and von Willebrand factor release - Used for hemophilia A, von Willebrand disease, and platelet dysfunction - Does not reverse warfarin's effect on vitamin K-dependent factors

Q: In a patient with severe COVID-19, why might dexamethasone be preferred over hydrocortisone?

Longer half-life and greater glucocorticoid activity. ***Longer half-life and greater glucocorticoid activity*** - **Dexamethasone** has a significantly longer biological half-life (36-54 hours) and greater anti-inflammatory potency (25-30x) than hydrocortisone, allowing for more sustained and potent immunosuppression in severe COVID-19. - Its higher **glucocorticoid activity** is crucial for dampening the severe inflammatory response (cytokine storm) seen in critical COVID-19 cases, which contributes to lung damage and multi-organ failure. - The **RECOVERY trial** demonstrated mortality benefit with dexamethasone 6 mg daily in severe COVID-19, establishing it as the standard of care. *Lower immunosuppressive effects* - This is **incorrect** as a reason to prefer dexamethasone; in severe COVID-19, we need **stronger**, not lower, immunosuppression to combat the exaggerated inflammatory response. - Dexamethasone's **higher potency** is precisely why it's preferred - it provides more effective suppression of the cytokine storm than hydrocortisone. *Lower impact on blood glucose levels* - This is **incorrect**; dexamethasone actually has a **greater** hyperglycemic effect than hydrocortisone due to its higher potency and longer duration of action. - While glucose elevation is a concern, the benefits of dexamethasone's potent anti-inflammatory effects in reducing mortality outweigh this manageable side effect in critically ill patients. *Fewer gastrointestinal side effects* - This is **incorrect**; dexamethasone does not have fewer GI side effects compared to hydrocortisone. Both corticosteroids can cause GI complications. - The primary consideration in severe COVID-19 is efficacy in reducing inflammation and mortality, where **dexamethasone** demonstrates superior benefit based on clinical trial evidence.

Q: A 30-year-old female with a new diagnosis of systemic lupus erythematosus (SLE) presents with fatigue and joint pain. Which medication is most likely to alleviate her symptoms?

Hydroxychloroquine. ***Hydroxychloroquine*** - This is the **first-line treatment** for most patients with SLE, especially for managing fatigue, joint pain, skin rashes, and serositis. - It has a good safety profile for long-term use and helps prevent **SLE flares** and reduce major organ damage. *Methotrexate* - This is a **disease-modifying antirheumatic drug (DMARD)** often used in SLE for severe arthritis or skin involvement, but it is not typically the initial choice for general fatigue and joint pain. - It requires close monitoring for **hepatic toxicity**, bone marrow suppression, and is contraindicated in pregnancy. *Cyclosporine* - This is an **immunosuppressant** reserved for more severe manifestations of SLE, such as **lupus nephritis** or refractory cases when other therapies have failed. - Its use is limited by potential adverse effects like **nephrotoxicity** and hypertension. *Prednisone* - This is a **corticosteroid** often used for acute flares or more severe manifestations of SLE due to its rapid anti-inflammatory and immunosuppressive effects. - However, it's generally not ideal for long-term, chronic management of mild to moderate symptoms like fatigue and joint pain due to significant **side effects** with prolonged use.

Q: A 55-year-old male presents with a painful right big toe, and his serum uric acid levels are high. Which drug is most appropriate to prevent further gout attacks?

Allopurinol. ***Allopurinol*** - **Allopurinol** is a **xanthine oxidase inhibitor** that reduces the production of uric acid, thereby lowering serum uric acid levels and preventing future gout attacks [1], [2]. - It is the most commonly prescribed **urate-lowering therapy (ULT)** for **prophylaxis** of recurrent gout [2]. *Metformin* - **Metformin** is an **oral hypoglycemic agent** used to treat **type 2 diabetes mellitus** by decreasing hepatic glucose production and increasing insulin sensitivity. - It has no role in the management or prevention of gout. *Atorvastatin* - **Atorvastatin** is an **HMG-CoA reductase inhibitor** (statin) used to lower **cholesterol** and **triglyceride levels** in patients with hyperlipidemia. - It does not impact uric acid metabolism or gout. *Propranolol* - **Propranolol** is a **non-selective beta-blocker** used to treat conditions such as **hypertension**, angina, and arrhythmias. - It has no effect on uric acid levels or the prevention of gout attacks.

Q: A patient with an autoimmune disease receives a biological agent that inhibits TNF-alpha. Identify the drug:

Infliximab. ***Infliximab*** - **Infliximab** is a **chimeric monoclonal antibody** that functions as a tumor necrosis factor-alpha (TNF-alpha) inhibitor, directly binding to and neutralizing TNF-alpha. - It is effectively used in treating several autoimmune conditions like **rheumatoid arthritis**, **Crohn's disease**, **psoriatic arthritis**, and **ankylosing spondylitis** by reducing inflammation. *Methotrexate* - **Methotrexate** is a **disease-modifying antirheumatic drug (DMARD)** and an **antimetabolite** that inhibits dihydrofolate reductase. - While used in autoimmune diseases, it primarily acts by **interfering with immune cell proliferation** and inflammation, not by directly inhibiting TNF-alpha. *Mycophenolate mofetil* - **Mycophenolate mofetil** is an **immunosuppressant** that selectively inhibits inosine monophosphate dehydrogenase, crucial for de novo purine synthesis in lymphocytes. - It is mainly used in **organ transplantation** to prevent rejection and in certain autoimmune conditions like lupus nephritis, not as a direct TNF-alpha inhibitor. *Azathioprine* - **Azathioprine** is a **prodrug** that is metabolized to 6-mercaptopurine, which then interferes with DNA synthesis, primarily affecting rapidly dividing cells like lymphocytes. - It is used as an immunosuppressant in **autoimmune diseases** and **transplant rejection**, but it does not directly target TNF-alpha.

Q: In a case of suspected drug overdose, the presence of which substance in urine would most strongly indicate the use of heroin?

6-acetylmorphine. ***6-acetylmorphine*** - **6-acetylmorphine (6-AM)** is a unique metabolite of heroin that is not produced from other opioids, making it a definitive marker for heroin use. - Its detection in urine confirms the recent use of **diacetylmorphine (heroin)**, as it has a relatively short half-life. *Morphine* - While heroin is metabolized to **morphine**, detecting morphine in urine alone is not specific to heroin use, as morphine can also be obtained from other sources like **morphine prescriptions** or **codeine metabolism**. - **Morphine** is an active metabolite of codeine and can also be found in individuals who have ingested poppy seeds, making it a less precise indicator of heroin. *Codeine* - **Codeine** is a separate opioid drug that can be prescribed for pain or cough, and its presence in urine indicates codeine use, not heroin use. - While codeine is metabolized to morphine, it does not produce **6-acetylmorphine**, distinguishing it from heroin. *Methadone* - **Methadone** is a synthetic opioid used for pain management and in the treatment of opioid dependence, and its presence in urine indicates methadone use. - It has a distinct chemical structure and metabolic pathway, entirely unrelated to **heroin metabolism**.

Q: A 60-year-old woman with type 2 diabetes presents with peripheral neuropathy. Which medication is the most appropriate for symptomatic treatment?

Gabapentin. ***Gabapentin*** - **Gabapentin** is a **first-line agent** (per ADA/NICE guidelines) for **diabetic peripheral neuropathy** (DPN) pain. - It works by binding to **voltage-gated calcium channels** and modulating **neurotransmitter release**, providing effective relief from **neuropathic pain**. - Other first-line options include **duloxetine**, **pregabalin**, and **tricyclic antidepressants**. *Metformin* - **Metformin** is a **first-line oral medication** for **type 2 diabetes** that **lowers blood glucose** by reducing hepatic glucose production and improving insulin sensitivity. - It does **not directly treat neuropathic pain** symptoms, though optimal glycemic control may slow neuropathy progression. *Insulin* - **Insulin** is used to **control blood glucose levels** by facilitating cellular glucose uptake. - While **good glycemic control** can prevent progression of neuropathy, insulin itself does **not provide symptomatic relief** for established neuropathic pain. *Lisinopril* - **Lisinopril** is an **ACE inhibitor** used for **hypertension**, **heart failure**, and **renal protection** in diabetic patients. - It has **no role** in the **symptomatic management of neuropathic pain**.

Question 1

Rituximab is used in all of the following conditions except:

Accepted Answer

Paroxysmal nocturnal hemoglobinuria

Answer

Rheumatoid arthritis

Answer

Systemic lupus erythematosus

Answer

Non-Hodgkin lymphoma

Question 2

Which drug is contraindicated in a patient with a history of porphyria?

Accepted Answer

Thiopental

Answer

Propofol

Answer

Midazolam

Answer

Etomidate

Question 3

A patient undergoing chemotherapy with cisplatin is at high risk for nephrotoxicity. Which preventive measure should be prioritized?

Accepted Answer

Aggressive intravenous hydration with saline

Answer

Administration of amifostine

Answer

Switch to carboplatin

Answer

Dose reduction of cisplatin

Question 4

A 60-year-old woman on warfarin (INR 6.5) presents with severe gastrointestinal bleeding and hemodynamic instability. Which intervention would most rapidly reverse the anticoagulation?

Accepted Answer

Fresh frozen plasma

Answer

Vitamin K

Answer

Protamine sulfate

Answer

Desmopressin

Question 5

In a patient with severe COVID-19, why might dexamethasone be preferred over hydrocortisone?

Accepted Answer

Longer half-life and greater glucocorticoid activity

Answer

Fewer gastrointestinal side effects

Answer

Lower immunosuppressive effects

Answer

Lower impact on blood glucose levels

Question 6

A 30-year-old female with a new diagnosis of systemic lupus erythematosus (SLE) presents with fatigue and joint pain. Which medication is most likely to alleviate her symptoms?

Accepted Answer

Hydroxychloroquine

Answer

Methotrexate

Answer

Cyclosporine

Answer

Prednisone

Question 7

A 55-year-old male presents with a painful right big toe, and his serum uric acid levels are high. Which drug is most appropriate to prevent further gout attacks?

Accepted Answer

Allopurinol

Answer

Metformin

Answer

Atorvastatin

Answer

Propranolol

Question 8

A patient with an autoimmune disease receives a biological agent that inhibits TNF-alpha. Identify the drug:

Accepted Answer

Infliximab

Answer

Azathioprine

Answer

Mycophenolate mofetil

Answer

Methotrexate

Question 9

In a case of suspected drug overdose, the presence of which substance in urine would most strongly indicate the use of heroin?

Accepted Answer

6-acetylmorphine

Answer

Codeine

Answer

Morphine

Answer

Methadone

Question 10

A 60-year-old woman with type 2 diabetes presents with peripheral neuropathy. Which medication is the most appropriate for symptomatic treatment?

Accepted Answer

Gabapentin

Answer

Metformin

Answer

Insulin

Answer

Lisinopril

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?